Figure 1
Proportion of benign and pathogenic variants in (A) Clinvitae training, PTT and test sets, (B) Clinvitae validation set, (C) ICR639 hereditary cancer dataset.
Figure 1 | Scientific Reports
Proportion of benign and pathogenic variants in (A) Clinvitae training, PTT and test sets, (B) Clinvitae validation set, (C) ICR639 hereditary cancer dataset.
